Metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a major role for transient elastography in the screening of significant liver fibrosis | Synapse
May 6, 2024
Metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a major role for transient elastography in the screening of significant liver fibrosis
Key Points
Key points are not available for this paper at this time.
Abstract
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)